Try our beta test site

Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart (BORG)

This study has been completed.
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
GlaxoSmithKline
AstraZeneca
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01798992
First received: February 22, 2013
Last updated: May 1, 2013
Last verified: January 2013